Etalocib
Etalocib (LY293111) is a selective diaryl ether carboxylic acid that inhibits the lipoxygenase pathway via LTB4 receptor antagonism and direct 5'-lipoxygenase inhibition. It exhibits antineoplastic activity and has been investigated in preclinical in vitro and in vivo cancer models, including pancreatic and leukemia studies.
Product Specifications
CAS Number
161172-51-6
Product Name Alternative
Asthma, Apoptosis, antiinflammatory, bronchiectasis, Etalocib, Inhibitor, Leukotriene Receptor, LeukotrieneReceptor, LTB4, LY 293111, LY-293111, LY293111, inhibit, Pulmonary, VML 295, VML295, VML-295
Field of Research
Cell Biology, Immunology & Inflammation, Pharmacology & Drug Discovery
Purity
98.21% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:3.3 mg/mL (6.06 mM) ; DMSO:100 mg/mL (183.62 mM)
Smiles
CCCc1c (OCCCOc2cc (O) c (cc2CC) -c2ccc (F) cc2) cccc1Oc1ccccc1C (O) =O
Molecular Formula
C33H33FO6
Molecular Weight
544.6
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
